Research Article
[Retracted] Correlation between Drug Resistance of Klebsiella Pneumonia and Antimicrobial Drug Usage
Table 2
Resistance rates of Klebsiella pneumoniae between 2016 and 2020 (%).
| Antibacterials | Years | 2016 | 2017 | 2018 | 2019 | 2020 |
| Amikacin | 2.31 | 3.29 | 6.12 | 7.09 | 4.14 | Imipenem | 0.35 | 0 | 6.12 | 6.10 | 9.31 | Meropenem | 4.5 | — | 0 | 38.46 | 48.57 | Fosfomycin | — | — | 0 | — | 0 | Ciprofloxacin | 22.37 | 12.84 | 19.05 | 27.03 | 33.79 | Gentamicin | 18.7 | 14.68 | 19.39 | 17.04 | 19.38 | Piperacillin | — | — | — | — | — | Piperacillin/tazobactam | 9.6 | 2.99 | 7.14 | 8.11 | 13.49 | Cefoperazone/sulbactam | 17.3 | 13.95 | — | — | — | Ampicillin/sulbactam | 41.2 | — | 24.21 | 29.15 | 30.74 | Ceftazidime | 19.98 | 15.13 | 19.73 | 18.24 | 23.10 | Aztreonam | 18.71 | 22.02 | 24.49 | 27.70 | 28.28 |
|
|